Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. NICE technology appraisal guidance 607
National Institute for Health and Care Excellence (NICE)
Record ID 32018011658
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta607
Year Published:
2019
URL for published report:
https://www.nice.org.uk/guidance/ta607
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Coronary Disease
- Rivaroxaban
- Thrombosis
- Peripheral Arterial Disease
- Coronary Artery Disease
- Factor Xa Inhibitors
- Anticoagulants
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.